<SEC-DOCUMENT>0001140361-25-021982-index.html : 20250610
<SEC-HEADER>0001140361-25-021982.hdr.sgml : 20250610
<ACCEPTANCE-DATETIME>20250609182328
ACCESSION NUMBER:		0001140361-25-021982
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250610
DATE AS OF CHANGE:		20250609
EFFECTIVENESS DATE:		20250610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MetaVia Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37809
		FILM NUMBER:		251035413

	BUSINESS ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeuroBo Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20191231

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>ny20049598x3_ars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: ny20049598x3_ars.pdf

</DOCUMENT>
</SEC-DOCUMENT>